Russell Patrick Sawyer , MD
Associate Professor of Clinical
Stetson Building
Suite 2300
260 Stetson Street
Cincinnati, Ohio 45219
Phone 513-558-2968
Email russell.sawyer@uc.edu
Education
MD: St. George's University Medical School Grenada, West Indies, 2013 (Medicine)
Bachelor of Science: University of California Davis Davis, CA, 2008 (Psychology, Minor-Neuroscience)
Residency: University of Cincinnati Medical Center Cincinnati, Ohio, 2016 (Neurology)
Fellowship: University of Cincinnati Medical Center Cincinnati, Ohio, 2017 (Behavioral Neurology)
Certifications
American Board of Psychiatry and Neurology (Neurology) (Certification Date: 09-11-2017 )
United Council for Neurologic Subspecialties (Certification Date: 11-30-2018 )
Clinical Interests
Cognitive Aging
Cognitive Disorders
Internal Medicine
Alzheimer's Disease
Amnesia
Aphasia
Chronic Traumatic Encephalopathy
Cognition Disorders
Dementia
Dysarthria
Early Anset Dementia
Epilepsy-Related Cognitive Dysfunction
Frontotemporal Lobar Degeneration
Lewy Body Dementia
Lewy Body Disease
Mad Cow Disease (Creutzfeldt-Jakob disease)
Memory Disorders
Metabolic Brain Disease
Mild Cognitive Impairment
Multi-Infarct Dementia
Multiple System Atrophy (MSA)
Neuralgias
Neuropathic Facial Pain
Normal Pressure Hydrocephalus
Orthostatic Hypotension (Postural Hypotension)
Paraphasic Error
Paroxysmal Hemicrania
Pick's Disease (Frontotemporal dementia)
Posterior Cortical Atrophy
Postherpetic Neuralgia
Post-Traumatic Headache
Prion Disease
Pseudobulbar Palsy
Pseudotumor Cerebri (Idiopathic Intracranial Hypertension)
Rare Cognitive Disorders
Stroke-Related Cognitive Dysfunction
Tauopathies
TDP-43 Proteinopathies
Vascular Cognitive Impairment
Vascular Dementia
Specialities
Behavioral Neurology & Neuropsychiatry
Neurology
Research and Practice Interests
Dementia, Memory Disorder, Cognitive Behavioral
Research Support
Grant: #R01AG072592 Investigators:Hyacinth, Hyacinth; Niu, Liang; Sawyer, Russell 09-15-2021 -05-31-2026 National Institute on Aging Cerebral small vessel disease burden and racial disparity in vascular cognitive impairment and Alzheimer's disease and its related dementias (transfer application) Role:Collaborator 1505134.00 Awarded Level:Federal
Grant: #AL002-2 (Invoke) 01-01-2023 -12-31-2025 PPD A Phase 2 Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of AL002 in Participants with Early Alzheimer's Disease Role:PI 0.00 Hold Level:Industry
Grant: #AL002-2 (Invoke) 01-01-2023 -12-31-2025 PPD A Phase 2 Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of AL002 in Participants with Early Alzheimer's Disease Role:PI 0.00 Hold Level:Industry
Grant: #Columbia; tba/tba Investigators:Sawyer, Russell 07-01-2023 -04-30-2026 National Institute on Aging Metformin in Alzheimer's dementia Prevention (MAP) Role:PI 244016.80 Hold Level:Federal
01-23-2024 -01-25-2027 PPD A Continuation Study of Latozinemab in Participants with Neurodegenerative Disease Role:PI 302631.81 Hold Level:Industry
01-23-2024 -01-25-2027 PPD A Continuation Study of Latozinemab in Participants with Neurodegenerative Disease Role:PI 302631.81 Hold Level:Industry
02-12-2024 -02-08-2027 IQVIA Clinical Trial Payments A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy, Safety, and Tolerability of BIIB080 in Subjects with Mild Cognitive Impairment Due to Alzheimer's Disease o Role:PI 372444.01 Active Level:Industry
02-12-2024 -02-08-2027 IQVIA Clinical Trial Payments A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy, Safety, and Tolerability of BIIB080 in Subjects with Mild Cognitive Impairment Due to Alzheimer's Disease o Role:PI 372444.01 Active Level:Industry
Grant: #1R01NS140155-01 Investigators:Demel, Stacie; Sawyer, Russell; Walsh, Kyle; Woo, Daniel -08-31-2028 National Institute of Neurological Disorders and Stroke Metabolomics of ICH recovery (METABOL-ICH) Role:Collaborator 0.00 Hold Level:Federal
Investigators:Sawyer, Russell 05-30-2024 -05-30-2028 PPD AL002: A Multicenter, Long Term Extension Study to Evaluate the safety, tolerability and efficacy of AL002 in Participants with Alzheimer's disease. Role:PI 111221.67 Hold Level:Industry
Publications
Peer Reviewed Publications
Sawyer, Russell P; Rodriguez-Porcel, Federico; Hagen, Matthew; Shatz, Rhonna; Espay, Alberto J (2017. ) Diagnosing the frontal variant of Alzheimer's disease: a clinician's yellow brick road.Journal of clinical movement disorders, , 4 ,2 More Information
Sawyer, Russell P; Sekar, Padmini; Osborne, Jennifer; Kittner, Steven J; Moomaw, Charles J; Flaherty, Matthew L; Langefeld, Carl D; Anderson, Christopher D; Rosand, Jonathan; Woo, Daniel (2018. ) Racial/ethnic variation of APOE alleles for lobar intracerebral hemorrhage.Neurology, , More Information
Merola, Aristide; Sawyer, Russell P; Artusi, Carlo Alberto; Suri, Ritika; Berndt, Zoe; Lopez-Castellanos, Jose' Ricardo; Vaughan, Jennifer; Vizcarra, Joaquin A; Romagnolo, Alberto; Espay, Alberto J (2018. ) Orthostatic hypotension in Parkinson disease: Impact on health care utilization.Parkinsonism & related disorders, , 47 ,45-49 More Information
Contact Information
Academic - Stetson Building
Suite 2300
CincinnatiĀ
Ohio, 45219
Phone: 513-558-2968
russell.sawyer@uc.edu